GlassScriptPhysician profile
Glenna Lea Grider
NPI 1740281567
$2,046.38
in general payments reported to CMS, 2019-2025
32 companies · $35.84 in 2025
The $35.84 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.02 · 2020: $13.65 · 2021: $214 · 2022: $496 · 2023: $654 · 2024: $572 · 2025: $35.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $955.67 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $115.87 | 2021-2024 | |
| Abbott Laboratories | $115.06 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.52 | 2020-2024 | Jardiance |
| Lilly USA, LLC | $78.30 | 2023-2024 | Zepbound |
| Daiichi Sankyo INC. | $64.55 | 2022-2023 | Injectafer |
| Novartis Pharmaceuticals Corporation | $64.14 | 2021-2023 | |
| Amgen INC. | $47.75 | 2019-2024 | Prolia, Evenity |
| Shield Therapeutics INC | $43.47 | 2023 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $41.62 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $35.21 | 2024 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $34.91 | 2022-2024 | Gardasil 9, Vaxelis, Capvaxive |
| Amarin Pharma, INC. | $28.59 | 2019-2021 | |
| Glaxosmithkline, LLC. | $26.27 | 2023-2024 | Arexvy, Shingrix |
| Cardiovascular Systems INC. | $23.75 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $23.17 | 2024 | Farxiga |
| Exact Sciences Corporation | $19.69 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $19.18 | 2023 | Dexcom G6 Transmitter |
| Ironwood Pharmaceuticals, INC | $18.57 | 2023 | Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $18.29 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.12 | 2022 | |
| Xeris Pharmaceuticals, INC. | $17.38 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.90 | 2022 | |
| Verrica Pharmaceuticals INC. | $16.11 | 2024 | Ycanth |
| Idorsia Pharmaceuticals US INC | $15.31 | 2022 | |
| Pfizer INC. | $15.15 | 2022 | |
| Kaleo, INC. | $13.79 | 2021 | |
| Dynavax Technologies Corporation | $13.27 | 2021 | |
| Ibsa Pharma INC. | $12.84 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.82 | 2022 | |
| Agile Therapeutics, INC. | $12.78 | 2021 | |
| Esperion Therapeutics, INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenna Grider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.